Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 253

1.

Abrogation of both short and long forms of latent transforming growth factor-β binding protein-1 causes defective cardiovascular development and is perinatally lethal.

Horiguchi M, Todorovic V, Hadjiolova K, Weiskirchen R, Rifkin DB.

Matrix Biol. 2015 Mar 21. pii: S0945-053X(15)00057-8. doi: 10.1016/j.matbio.2015.03.006. [Epub ahead of print]

2.

Isolation and cytokine analysis of lamina propria lymphocytes from mucosal biopsies of the human colon.

Bowcutt R, Malter LB, Chen LA, Wolff MJ, Robertson I, Rifkin DB, Poles M, Cho I, Loke P.

J Immunol Methods. 2015 Mar 10. pii: S0022-1759(15)00063-0. doi: 10.1016/j.jim.2015.02.012. [Epub ahead of print]

PMID:
25769417
3.

Mutations in the latent TGF-beta binding protein 3 (LTBP3) gene cause brachyolmia with amelogenesis imperfecta.

Huckert M, Stoetzel C, Morkmued S, Laugel-Haushalter V, Geoffroy V, Muller J, Clauss F, Prasad MK, Obry F, Raymond JL, Switala M, Alembik Y, Soskin S, Mathieu E, Hemmerlé J, Weickert JL, Dabovic BB, Rifkin DB, Dheedene A, Boudin E, Caluseriu O, Cholette MC, Mcleod R, Antequera R, Gellé MP, Coeuriot JL, Jacquelin LF, Bailleul-Forestier I, Manière MC, Hul W, Bertola D, Dollé P, Verloes A, Mortier G, Dollfus H, Bloch-Zupan A.

Hum Mol Genet. 2015 Feb 10. pii: ddv053. [Epub ahead of print]

4.

Mechanisms of tendon injury and repair.

Thomopoulos S, Parks WC, Rifkin DB, Derwin KA.

J Orthop Res. 2015 Jan 29. doi: 10.1002/jor.22806. [Epub ahead of print]

PMID:
25641114
5.

Function of latent TGFβ binding protein 4 and fibulin 5 in elastogenesis and lung development.

Dabovic B, Robertson IB, Zilberberg L, Vassallo M, Davis EC, Rifkin DB.

J Cell Physiol. 2015 Jan;230(1):226-36. doi: 10.1002/jcp.24704.

PMID:
24962333
6.

LAP degradation product reflects plasma kallikrein-dependent TGF-β activation in patients with hepatic fibrosis.

Hara M, Kirita A, Kondo W, Matsuura T, Nagatsuma K, Dohmae N, Ogawa S, Imajoh-Ohmi S, Friedman SL, Rifkin DB, Kojima S.

Springerplus. 2014 May 1;3:221. doi: 10.1186/2193-1801-3-221. eCollection 2014.

7.

Kindlin-1 controls Wnt and TGF-β availability to regulate cutaneous stem cell proliferation.

Rognoni E, Widmaier M, Jakobson M, Ruppert R, Ussar S, Katsougkri D, Böttcher RT, Lai-Cheong JE, Rifkin DB, McGrath JA, Fässler R.

Nat Med. 2014 Apr;20(4):350-9. doi: 10.1038/nm.3490. Epub 2014 Mar 30.

8.

Genetic suppression of inflammation blocks the tumor-promoting effects of TGF-β in gastric tissue.

Ota M, Horiguchi M, Fang V, Shibahara K, Kadota K, Loomis C, Cammer M, Rifkin DB.

Cancer Res. 2014 May 1;74(9):2642-51. doi: 10.1158/0008-5472.CAN-13-3404. Epub 2014 Mar 3.

PMID:
24590056
9.

Noninvasive diagnosis and management of spontaneous intracranial hypotension in patients with marfan syndrome: Case Report and Review of the Literature.

Bassani L, Graffeo CS, Behrooz N, Tyagi V, Wilson T, Penaranda S, Zagzag D, Rifkin DB, Barcellos-Hoff MH, Fatterpekar G, Placantonakis D.

Surg Neurol Int. 2014 Jan 21;5:8. doi: 10.4103/2152-7806.125629. eCollection 2014.

10.

Sex differences in the pituitary transforming growth factor-β1 system: studies in a model of resistant prolactinomas.

Recouvreux MV, Lapyckyj L, Camilletti MA, Guida MC, Ornstein A, Rifkin DB, Becu-Villalobos D, Díaz-Torga G.

Endocrinology. 2013 Nov;154(11):4192-205. doi: 10.1210/en.2013-1433. Epub 2013 Sep 5.

11.

Unchaining the beast; insights from structural and evolutionary studies on TGFβ secretion, sequestration, and activation.

Robertson IB, Rifkin DB.

Cytokine Growth Factor Rev. 2013 Aug;24(4):355-72. doi: 10.1016/j.cytogfr.2013.06.003. Epub 2013 Jul 12. Review.

12.

GPR15-mediated homing controls immune homeostasis in the large intestine mucosa.

Kim SV, Xiang WV, Kwak C, Yang Y, Lin XW, Ota M, Sarpel U, Rifkin DB, Xu R, Littman DR.

Science. 2013 Jun 21;340(6139):1456-9. doi: 10.1126/science.1237013. Epub 2013 May 9.

13.

Latent TGF-β binding protein 4 promotes elastic fiber assembly by interacting with fibulin-5.

Noda K, Dabovic B, Takagi K, Inoue T, Horiguchi M, Hirai M, Fujikawa Y, Akama TO, Kusumoto K, Zilberberg L, Sakai LY, Koli K, Naitoh M, von Melchner H, Suzuki S, Rifkin DB, Nakamura T.

Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2852-7. doi: 10.1073/pnas.1215779110. Epub 2013 Feb 4.

14.

Production of gastrointestinal tumors in mice by modulating latent TGF-β1 activation.

Shibahara K, Ota M, Horiguchi M, Yoshinaga K, Melamed J, Rifkin DB.

Cancer Res. 2013 Jan 1;73(1):459-68. doi: 10.1158/0008-5472.CAN-12-3141. Epub 2012 Nov 1.

15.

Matrix control of transforming growth factor-β function.

Horiguchi M, Ota M, Rifkin DB.

J Biochem. 2012 Oct;152(4):321-9. Epub 2012 Aug 24. Review.

16.

Thrombospondin-1 (TSP-1) analogs ABT-510 and ABT-898 inhibit prolactinoma growth and recover active pituitary transforming growth factor-β1 (TGF-β1).

Recouvreux MV, Camilletti MA, Rifkin DB, Becu-Villalobos D, Díaz-Torga G.

Endocrinology. 2012 Aug;153(8):3861-71. doi: 10.1210/en.2012-1007. Epub 2012 Jun 14.

17.

Specificity of latent TGF-β binding protein (LTBP) incorporation into matrix: role of fibrillins and fibronectin.

Zilberberg L, Todorovic V, Dabovic B, Horiguchi M, Couroussé T, Sakai LY, Rifkin DB.

J Cell Physiol. 2012 Dec;227(12):3828-36. doi: 10.1002/jcp.24094.

18.

Is losartan the drug for all seasons?

Ramirez F, Rifkin DB.

Curr Opin Pharmacol. 2012 Apr;12(2):223-4. doi: 10.1016/j.coph.2012.02.007. Epub 2012 Mar 21. No abstract available.

19.

An osteoblast-derived proteinase controls tumor cell survival via TGF-beta activation in the bone microenvironment.

Thiolloy S, Edwards JR, Fingleton B, Rifkin DB, Matrisian LM, Lynch CC.

PLoS One. 2012;7(1):e29862. doi: 10.1371/journal.pone.0029862. Epub 2012 Jan 4.

20.

LTBPs, more than just an escort service.

Todorovic V, Rifkin DB.

J Cell Biochem. 2012 Feb;113(2):410-8. doi: 10.1002/jcb.23385. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk